Wait Time

ER Wait Times

Urgent Care Wait Times

Donate to CCHC My Cape Cod Health
VIEW SECTION LINKS

Published on October 18, 2012

CCHC to Notify Patients who received NECC products

October 2012

Out of an abundance of caution and on the advice of the FDA, Cape Cod Healthcare has decided to notify patients who received any injectable drug produced by NECC on or after May 21, 2012, even though no CCHC facility received any of the tainted NECC steroid medication and no Cape Cod Healthcare patient received any contaminated medications implicated in the outbreak.

Cape Cod Healthcare reviewed every chart for patients who received any injectable NECC medication on or after May 21, 2012 and we will proactively send letters today to 1,515 patients informing them of the situation, in accordance with the FDA recommendation. The letter informs each patient of the injectable NECC medication that he or she received and specifically notifies them that they did not receive any of the drugs presently implicated in the outbreak.

Neither Cape Cod Hospital nor Falmouth Hospital, nor either of Cape Cod Healthcare’s pain centers in Hyannis or Falmouth have used any of the preservative free methylprednisolone acetate that has been linked to the fungal meningitis outbreak in other parts of the country. The Centers for Disease Control and the FDA has also identified additional drugs produced by NECC that are now implicated in the outbreak. Cape Cod Healthcare has not used any of these implicated medications.

If patients notified by letter develop any of the following symptoms, they should seek medical care: fever, headache, stiff neck, nausea and vomiting, sensitivity to light, dizziness, and confusion. CDC is not recommending any treatment for patients who have been exposed to NECC produced medications but have no symptoms of illness at this time. You can access more information at the following CDC website: http://www.cdc.gov/HAI/menigitis.html.

Cape Cod Healthcare has removed all NECC drugs from our pharmacies so as to eliminate any future concerns regarding drugs produced by NECC. Patients who have any questions regarding this letter are being asked to call the Cape Cod Healthcare's Infection Prevention Hotline at 508-862-5033.

Media Inquiries

All media inquiries should be directed to Robin Lord, Director of Communications.

Phone: 508-862-7891

Cell: 774-236-9602

rlord@capecodhealth.org